|
PLOD2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.895500E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.958500E-03 |
| Normal-vs-Stage2 |
5.108800E-01 |
| Normal-vs-Stage3 |
9.714000E-01 |
| Normal-vs-Stage4 |
1.297250E-01 |
| Stage1-vs-Stage2 |
3.642200E-01 |
| Stage1-vs-Stage3 |
4.837900E-03 |
| Stage1-vs-Stage4 |
7.527200E-01 |
| Stage2-vs-Stage3 |
4.933800E-01 |
| Stage2-vs-Stage4 |
5.840000E-01 |
| Stage3-vs-Stage4 |
9.612000E-02 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.733020E-01 |
| Normal-vs-AfricanAmerican |
5.347900E-02 |
| Normal-vs-Asian |
3.517500E-02 |
| Caucasian-vs-AfricanAmerican |
1.207790E-01 |
| Caucasian-vs-Asian |
1.588010E-01 |
| AfricanAmerican-vs-Asian |
6.828400E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.779200E-01 |
| Normal-vs-Female |
1.059890E-02 |
| Male-vs-Female |
7.736000E-02 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.124600E-03 |
| Normal-vs-Age(41-60Yrs) |
2.333000E-01 |
| Normal-vs-Age(61-80Yrs) |
4.917800E-01 |
| Normal-vs-Age(81-100Yrs) |
7.483800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.338000E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.249600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.847580E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
7.202000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.225600E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.134200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
4.917200E-01 |
| Classical-VS-Follicular |
2.847600E-01 |
| Classical-VS-Other |
8.464000E-01 |
| Classical-VS-Normal |
3.326300E-02 |
| Tall-VS-Follicular |
1.638010E-01 |
| Tall-VS-Other |
5.820200E-01 |
| Tall-VS-Normal |
4.798200E-01 |
| Follicular-VS-Other |
8.432600E-01 |
| Follicular-VS-Normal |
2.104200E-02 |
| Other-VS-Normal |
2.837800E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.170440E-01 |
| Normal-vs-N1 |
1.178950E-01 |
| N0-vs-N1 |
6.990800E-01 |
|
|
